Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)

South Korea · Delayed Price · Currency is KRW

10,210

+250 (2.51%)

At close: Jul 31, 2026

Ahn-Gook Pharmaceutical Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	330,050	306,874	271,116	233,676	205,389	163,534
Revenue Growth	17.40%	13.19%	16.02%	13.77%	25.59%	14.07%
Gross Profit	218,129	200,302	167,896	140,571	126,279	101,018
Operating Income	19,961	9,798	6,678	5,061	9,381	-1,084
Net Income	16,268	7,481	16,845	1,290	6,875	3,939
Earnings Per Share	1431.88	658.20	1482.00	113.51	604.00	343.93
EPS Growth	28.89%	-55.59%	1205.57%	-81.21%	75.62%	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	66,335	54,050	29,738	35,446	38,442	47,460
Total Debt	78,058	73,075	77,724	17,679	20,005	20,191
Net Cash (Debt)	-11,723	-19,024	-47,986	17,767	18,437	27,269
Net Cash Growth	-	-	-	-3.63%	-32.39%	-7.45%
Net Cash Per Share	-1031.86	-1673.90	-4221.58	1563.26	1620.25	2380.83

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	50,794	45,683	4,914	-1,328	1,788	1,472
Capital Expenditures	-9,150	-8,465	-75,887	-5,474	-2,931	-4,035
Free Cash Flow	41,643	37,218	-70,972	-6,802	-1,143	-2,563
Free Cash Flow Growth	373.83%	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	66.09%	65.27%	61.93%	60.16%	61.48%	61.77%
Operating Margin	6.05%	3.19%	2.46%	2.17%	4.57%	-0.66%
Pretax Margin	5.74%	2.51%	7.47%	1.83%	3.59%	2.33%
Profit Margin	4.93%	2.44%	6.21%	0.55%	3.35%	2.41%
FCF Margin	12.62%	12.13%	-26.18%	-2.91%	-0.56%	-1.57%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	440.000	-	-	-	-	-
Dividend Per Share Growth	43.86%	-	-	-	-	-
Dividend Yield	4.31%	-	-	-	-	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	7.33	12.85	4.41	82.90	15.19	31.13
Forward PE	-	71.34	71.34	71.34	71.34	71.34
P/FCF Ratio	2.86	2.58	-	-	-	-
PS Ratio	0.36	0.31	0.27	0.46	0.51	0.75